Maxacalcitol-d6(Synonyms: 马沙骨化醇-D6)

上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白、同位素标记物,专注于信号通路和疾病研究领域。
Maxacalcitol-d6 (Synonyms: 马沙骨化醇-D6) 纯度: 96.80%

Maxacalcitol-D6是Maxacalcitol (22-Oxacalcitriol)的氘化形式,是非血钙维生素D3类似物和VDR样受体VDR配体。

Maxacalcitol-d6(Synonyms: 马沙骨化醇-D6)

Maxacalcitol-d6 Chemical Structure

规格 价格 是否有货 数量
1 mg ¥15345 In-stock
5 mg ¥51150 In-stock
10 mg   询价  
50 mg   询价  

* Please select Quantity before adding items.

生物活性

Maxacalcitol-D6 is the deuterated form of Maxacalcitol (22-Oxacalcitriol), which is a non-calcemic vitamin D3 analog and VDR ligand of VDR-like receptors. IC50 value: Target: Maxacalcitol (22-Oxacalcitriol)suppresses parathyroid hormone (PTH) mRNA expression in vitro and in vivo. Maxacalcitol exhibits similar effects to calcitriol in osteoblast-like cells. Maxacalcitol(22-Oxacalcitriol) inhibits tumor growth of osteosarcoma in vitro in combination with all-trans retinoic acid.

分子量

424.65

Formula

C26H36D6O4

中文名称

马沙骨化醇-D6;玛莎骨化醇-D6

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

4°C, protect from light, stored under nitrogen

*该产品在溶液状态不稳定,建议您现用现配,即刻使用。

参考文献
  • [1]. Monier-Faugere et al 22-Oxacalcitriol suppresses secondary hyperparathyroidism without inducing low bone turnover in dogs with renal failure. Kidney Int. (1999)55 821.

    [2]. Barroga et al Inhibitory effects of 22-oxa-calcitriol and all-trans retinoic acid on the growth of a canine osteosarcoma derived cell-line in vivo and its pulmonary metastasis in vivo. Res.Vet.Sci. (2000)68 79.

    [3]. Inoue K, Matsui I, Hamano T, Fujii N, Shimomura A, Nakano C, Kusunoki Y, Takabatake Y, Hirata M, Nishiyama A, Tsubakihara Y, Isaka Y, Rakugi H.Maxacalcitol ameliorates tubulointerstitial fibrosis in obstructed kidneys by recruiting PPM1A/VDR complex to pSmad3.Lab Invest. 2012 Aug 27.

    [4]. Karashima T, Hashikawa K, Ono F, Eguchi H, Hamada T, Ishii N, Dainichi T, Yasumoto S, Tsuruta D, Hashimoto T.Successful Treatment of Bowen’s Disease with Topical Maxacalcitol.Acta Derm Venereol. 2012 Jan 26.

所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务